Background

GLOBAL AGROVET
RESEARCH CONFERENCE - 2K25

Calendar10 - 11 November 2025
CalendarDusit Thani, Dubai
message
Themed at: “One Health: Integrating Agriculture and Animal Science for a Sustainable Future."

POWERED BY ARCC JOURNALS

ARCC Logo
blog image
image

24 Apr 2025

Antibody-based compositions for various treatments

This composition consists of antibody-like molecules specifically engineered to target and neutralize pathogens and abnormal cells in the animal's body.

How is antibody-based composition changing Animal Healthcare?

Even though the domain of antibody-based treatment compositions has been explored for many years, substantial patent filings have occurred recently, and it is anticipated that this domain will continue to grow in the coming years as well.

This pattern is due to the rapid increase in new diseases, animal antibiotic resistance, and the development of cancer treatment.

Novozyme and Bactolife collaborated to develop single-domain antibodies to prevent or treat coccidiosis in poultry and reduce parasite infection risks in dogs, cats, birds, or rabbits. This invention is a solution for curbing antimicrobial resistance in animals.

Zoetis has developed antibodies and polynucleotides for treating and managing fibrosis-related disorders in canines and felines.

Vetoquinol has developed canine antibodies to treat itch and inflammatory skin conditions caused by atopic dermatitis and allergies in dogs.

Intervet has developed human nerve growth factor (NGF) antibodies for pain treatment in canines and felines.

The United States Government has developed a method to construct and produce single-domain antibodies (sdAbs) for targeting the Venezuelan equine encephalitis virus (VEEV).

These antibodies are being used to detect and provide suitable treatment upon detection. The antibodies can be immobilized, used as reporters, and combined with another suitable medicine carrier.

SHARE :

blog imageblog image
;